Life AI Net
홈
아카이브
계산기
디렉토리
뉴스레터
로그인
한국어
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
홈
아카이브
계산기
디렉토리
뉴스레터
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
로그인
홈
아카이브
계산기
디렉토리
More
실시간
Endpoints News
#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live
FierceBiotech
Alumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospects
Labiotech
Freeze variability, not progress: strengthen your cell therapy supply chain from the start
Endpoints News
Supreme Court preserves mail access for abortion pill
FierceBiotech
Aardvark to dig into phase 3 data early after FDA imposes hold
Siemens Healthineers
Siemens Healthineers Wins Key US Clearances As Valuation Gap Widens - simplywall.st
BioNTech
BioNTech’s Clinical and Corporate Overhaul: Cancer Data Improves as COVID Era Ends - AD HOC NEWS
Every Green
Biotech Just Hit Fast Forward. Is Europe’s Seed Sector Ready? - seedworld.com
IQVIA
IQVIA And Kexing Biopharm Advance Global Biosimilar Expansion Through AI Enabled Strategic Collaboration - BioPharma APAC
Illumina
Corvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock Titan
FierceBiotech
Chutes & Ladders—AC Immune CEO bids adieu
Eli Lilly
Is Eli Lilly Going To $1,100? - 24/7 Wall St.
Endpoints News
#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live
FierceBiotech
Alumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospects
Labiotech
Freeze variability, not progress: strengthen your cell therapy supply chain from the start
Endpoints News
Supreme Court preserves mail access for abortion pill
FierceBiotech
Aardvark to dig into phase 3 data early after FDA imposes hold
Siemens Healthineers
Siemens Healthineers Wins Key US Clearances As Valuation Gap Widens - simplywall.st
BioNTech
BioNTech’s Clinical and Corporate Overhaul: Cancer Data Improves as COVID Era Ends - AD HOC NEWS
Every Green
Biotech Just Hit Fast Forward. Is Europe’s Seed Sector Ready? - seedworld.com
IQVIA
IQVIA And Kexing Biopharm Advance Global Biosimilar Expansion Through AI Enabled Strategic Collaboration - BioPharma APAC
Illumina
Corvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock Titan
FierceBiotech
Chutes & Ladders—AC Immune CEO bids adieu
Eli Lilly
Is Eli Lilly Going To $1,100? - 24/7 Wall St.
아카이브
이 기사는 아카이브에서 찾을 수 없습니다.